...
机译:在同种异体干细胞移植后复发后,对B细胞恶性肿瘤进行的供体衍生的CD19-重定向的病毒特异性T细胞进行输注:1期研究
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
National Heart Lung and Blood Institute National Institutes of Health Bethesda MD United;
National Heart Lung and Blood Institute National Institutes of Health Bethesda MD United;
University of Texas MD Anderson Cancer Center Houston TX United States;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
University of Texas MD Anderson Cancer Center Houston TX United States;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
Center for Cell and Gene Therapy Baylor College of Medicine 1102 Bates St. Houston TX 77030;
机译:同种异体干细胞移植后,输注供体来源的CD19重定向的病毒特异性T细胞用于B细胞恶性肿瘤的复发:1期研究
机译:在异基因干细胞移植后复发的患者中反复输注供体来源的细胞因子诱导的杀伤细胞:I期研究|血液学
机译:同种异体干细胞移植后复发或难治性B细胞淋巴瘤中使用三功能双特异性抗CD3 x抗CD20抗体FBTA05(Bi20)和供体淋巴细胞输注(DLI)进行免疫治疗:研究者驱动的开放标签研究方案,非随机,不受控制,剂量递增的I / II试验阶段
机译:SmartTransplantation-同种异体干细胞移植作为医学专家系统的模型
机译:接受同种异体造血干细胞移植的患者的供体选择:加拿大造血干细胞移植医生的优先事项评估。
机译:Cruz CRYMicklethwaite KPSavoldo B等。同种异体干细胞移植后输注供体来源的CD19重定向的病毒特异性T细胞用于B细胞恶性肿瘤复发:一项1期研究。血液。 2013; 122(17):2965-2973。
机译:同种异体干细胞移植后复发或难治性B细胞淋巴瘤中使用三功能双特异性抗CD3 x抗CD20抗体FBTA05(Bi20)和供体淋巴细胞输注(DLI)进行免疫治疗:研究者驱动的开放标签研究方案,非随机,不受控制,剂量递增的I / II试验阶段